Facebook
Twitter
Telegram
Report an ErrorCTI BioPharma Corp. Financial Statements 2011-2024 | CTIC
Annual Financial Statements CTI BioPharma Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
551 M | 171 M | 236 M | 70.1 M | 65.6 M | 110 M | 130 M | 237 M | 327 M | 379 M | 84.9 M | 187 M |
Shares |
115 M | 90.1 M | 71.1 M | 58 M | 56.1 M | 36.4 M | 27.9 M | 18.8 M | 14.9 M | 11.4 M | 5.81 M | 3.43 M |
Historical Prices |
4.8 | 1.9 | 3.25 | 0.98 | 1.02 | 4.02 | 4.21 | 5.4 | 23.4 | 38.5 | 13.5 | 64.5 |
Net Income |
-93 M | -97.9 M | -52.5 M | -40 M | -29.3 M | -40.7 M | -52 M | -119 M | -93.4 M | -42.7 M | -101 M | -62.4 M |
Revenue |
53.9 M | - | 4.2 K | 3.34 M | 26.3 M | 25.1 M | 57.4 M | 16.1 M | 60.1 M | 34.7 M | - | - |
Cost of Revenue |
3.51 M | - | - | - | 879 K | 364 K | - | - | - | - | - | - |
Gross Profit |
- | - | 4.2 K | - | 25.4 M | 24.8 M | 56 M | 14.2 M | 59.2 M | 34.5 M | - | - |
Operating Income |
-79.8 M | -95.3 M | -47.8 M | -40.7 M | -32.9 M | -39.5 M | -49.2 M | -117 M | -86.2 M | -41.5 M | -101 M | -62.2 M |
Interest Expense |
13.1 M | 2.42 M | 828 K | 1 M | 1.21 M | 1.87 M | 2.61 M | 2.1 M | 1.95 M | 1.03 M | 56 K | 870 K |
EBITDA |
-77.8 M | -94.8 M | -47.2 M | -39.4 M | -31.6 M | -38.8 M | -48.3 M | -116 M | -85.1 M | -39.8 M | -98.2 M | -70.8 M |
Operating Expenses |
- | - | 47.8 M | 43.3 M | 57.6 M | 64.3 M | 105 M | 131 M | 145 M | 75.9 M | 101 M | 73.2 M |
General and Administrative Expenses |
84.8 M | 56.2 M | 17.6 M | 19.2 M | 21.2 M | 31.4 M | 45.3 M | 54 M | 56.2 M | 42.3 M | 38.2 M | 38.3 M |
All numbers in USD currency
Quarterly Income Statement CTI BioPharma Corp.
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
132 M | 131 M | 122 M | 109 M | 99.8 M | 99.8 M | 93.8 M | 92.3 M | 76.4 M | 75.9 M | 73.7 M | 73.7 M | 62.5 M | 58 M | 58 M | 58 M | 58 M | 58 M | 58 M | 57.9 M | 50.3 M | 43 M | 42.9 M | 31.7 M | 28 M | 28.2 M | 28 M | 28 M | 27.8 M | 28 M | 176 M | 175 M | 174 M | 177 M | 145 M | 144 M | 142 M | 146 M | 111 M | 108 K | 107 M | 110 M | 52.9 M | 42.5 M | 40.8 M | 40.6 M | 37 M | 165 M | 203 M |
Net Income |
-13.4 M | - | -15.7 M | -22.7 M | -37.2 M | - | -24.2 M | -19.7 M | -17.3 M | - | -11.3 M | -14 M | -12.2 M | - | -10 M | -11 M | -10.8 M | - | -14.8 M | -11.3 M | -4.02 M | -14.3 M | -12 M | 5.4 M | -19.8 M | -6.37 M | -29.2 M | -19.8 M | 3.31 M | -25.6 M | -32.6 M | -32.6 M | -28.6 M | -41.6 M | 4.6 M | -27.4 M | -29 M | 10.2 M | -15.5 M | -18 M | -19.4 M | -18.6 M | -15.2 M | -50.1 M | -17.4 M | -8.97 M | -16.7 M | -17 M | -19.7 M |
Revenue |
24.1 M | - | 18.2 M | 12.3 M | 2.3 M | - | - | - | - | - | - | - | - | - | 2.29 M | 416 K | 640 K | - | 723 K | 613 K | 10.5 M | 462 K | 1.7 M | 22.2 M | 754 K | 9.14 M | 4.43 M | 7.36 M | 36.5 M | 11.3 M | 964 K | 1.1 M | 2.73 M | 17.8 M | 39.5 M | 1.34 M | 1.41 M | 32.9 M | 362 K | 306 K | 1.13 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
1.22 M | - | 1.15 M | 917 K | 278 K | - | - | - | - | - | - | - | - | - | - | - | - | - | 114 K | 588 K | - | - | 69 K | 78 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -84 K | -69 K | 149 K | 493 K | 151 K | 751 K | 815 K | 1.03 M | 351 K | -86 K | 669 K | 622 K | 2.18 M | 1.77 M | 946 K | 1.12 M | 487 K | 349 K | 270 K | 1.07 M | - | - | - | - | - | - | - | - |
Operating Income |
-9.23 M | - | -12.2 M | -18.9 M | -35.1 M | - | -23.4 M | -19.5 M | -17.1 M | - | -11 M | -10 M | -11.9 M | - | -9.71 M | -11 M | -10.5 M | - | -14.8 M | -14 M | -4.34 M | - | -11.8 M | 5.27 M | -19.3 M | - | -28.7 M | -19.1 M | 4.13 M | - | -32 M | -31 M | -27.5 M | - | 7.47 M | -26.7 M | -27.7 M | - | -15.5 M | -17.9 M | -18.5 M | -18.8 M | -15.1 M | -49.4 M | -18.1 M | -9.91 M | -15.3 M | -16.9 M | -20.1 M |
Interest Expense |
4.18 M | - | 3.56 M | 3.76 M | 2.06 M | - | 653 K | 167 K | 187 K | - | 115 K | 137 K | 167 K | - | 240 K | 269 K | 294 K | - | 308 K | 297 K | 288 K | - | 457 K | 488 K | 534 K | - | 634 K | 677 K | 714 K | - | 1.29 M | 597 K | 494 K | - | 472 K | 467 K | 464 K | - | 316 K | 316 K | 48 K | - | 43 K | 3 K | 5 K | - | 161 K | 222 K | 389 K |
EBITDA |
-8.71 M | - | -10.8 M | -18 M | -34.8 M | - | -23 M | -19.2 M | -16.9 M | - | -10.6 M | -9.73 M | -11.8 M | - | -9.3 M | -10.7 M | -10.4 M | - | -14.3 M | -13.7 M | -4.18 M | - | -11.2 M | 5.65 M | -19.1 M | - | -28 M | -18.6 M | 4.36 M | - | -31.2 M | -30.5 M | -27.2 M | - | 8.35 M | -26.1 M | -27.3 M | - | -14.3 M | -17 M | -18.1 M | -18.8 M | -13.4 M | -48.3 M | -17.6 M | -9.91 M | -13.5 M | -15.9 M | -19.6 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
21.9 M | - | 21.5 M | 21.6 M | 18 M | - | 13.7 M | 10.2 M | 7.63 M | - | 4.05 M | 3.8 M | 4.47 M | - | 4.4 M | 5.05 M | 5.21 M | - | 5.76 M | 5.49 M | 5.5 M | - | 5.8 M | 7.96 M | 10.7 M | - | 15.2 M | 9.57 M | 11.3 M | - | 13.7 M | 12.6 M | 12.3 M | - | 12.6 M | 13.8 M | 16.8 M | - | 8.53 M | 10.1 M | 11.1 M | - | 7.76 M | 11.3 M | 9.93 M | - | 7.76 M | 8.96 M | 8.58 M |
All numbers in USD currency